Palmer Square BDC (PSBD) Q4 2025 earnings review
NAV Erosion Continues as Portfolio Contraction Weighs on Earnings
Palmer Square BDC's Q4 results portray a fund playing intense defense, resulting in a shrinking footprint. Total Investment Income fell 14.5% YoY to $29.8M, driven by a deliberate contraction of the portfolio, as repayments outpaced new funding by $56.9M. The most pressing issue is the relentless decline in Net Asset Value (NAV), which dropped to $14.85—marking the fifth consecutive quarterly decline, heavily impacted by $20M in unrealized depreciation. On the positive side, credit quality is immaculate: non-accruals collapsed to just 0.09% of fair value, and PIK income remains virtually non-existent at 1.45%. While the $0.36 base dividend remains well-covered by $0.41 in Net Investment Income, the persistent destruction of book value makes the high dividend yield look increasingly like a yield trap.
🐂 Bull Case
Management successfully resolved prior problem credits, driving non-accruals down to a negligible 0.09% of fair value. Furthermore, 99.9% of the portfolio is income-producing with minimal PIK (1.45%), highlighting exceptional cash flow quality.
The company commands $311.3M in available liquidity. By deliberately allowing the portfolio to shrink during a period of tight spreads, PSBD is perfectly positioned to deploy capital if software/AI-induced market volatility widens secondary loan discounts.
🐻 Bear Case
NAV has declined exactly 10% YoY ($16.50 to $14.85), largely due to persistent realized and unrealized losses ($18.4M this quarter alone). A BDC cannot sustainably grow dividends if its book value is constantly eroding.
The portfolio contracted from $1.41B in 24Q4 to $1.20B in 25Q4. With $148.3M in repayments completely dwarfing $91.4M in Q4 originations, baseline earnings power is structurally lowering.
⚖️ Verdict: 🔴
Bearish. While management's disciplined refusal to stretch for bad loans is commendable, a BDC that shrinks its portfolio by 14% and its NAV by 10% in a single year is moving in the wrong direction. The defensive posture has successfully protected against defaults, but the mark-to-market pain is punishing shareholders.
Key Themes
Portfolio Contraction Dragging Down Top Line
PSBD experienced another quarter of negative net deployment. New fundings totaled $91.4M, but were overwhelmed by $148.3M in sales and repayments. This dynamic has reduced total investments at fair value from $1.41B at the end of 2024 to $1.20B at the end of 2025. Consequently, Total Investment Income is decelerating, falling 14.5% YoY to $29.8M. Management is intentionally waiting out a tight spread environment, but the math is unforgiving: fewer assets generate fewer dollars.
Severe Mark-to-Market Pain
Despite low defaults, the portfolio suffered $18.4M in net realized and unrealized losses in Q4 (comprising $20M of unrealized depreciation offset by minor gains on exits). This marks a severe reversal from Q4 2024, which saw only $2.9M in losses. Management attributed this to broad market volatility and spread movements, rather than fundamental credit impairment, but the resulting erosion in shareholder equity is highly damaging.
Immaculate Credit Metrics
If there is a silver lining to the conservative strategy, it is the fortress-like health of the remaining assets. Non-accruals dropped from 0.40% in Q3 down to a microscopic 0.09% at fair value. Furthermore, PIK (Payment-in-Kind) income was only $431.8K, a mere 1.45% of total investment income. Management actively cut exposure to First Brands—a troubled asset flagged last quarter—preventing it from infecting the broader portfolio.
Navigating AI Disruption Fears in Software
Faced with intense market scrutiny over BDC exposure to software loans amidst the AI boom, management proactively defended their book. PSBD's software exposure sits at a manageable 11% (below the ~20% BDC industry average). The company stressed they avoid fast-growing, negative-cash-flow companies and commoditized tools (like basic marketing automation), focusing exclusively on deeply embedded, mission-critical ERP and cybersecurity platforms backed by massive sponsor equity.
Syndicated/Private Flexibility Showcased
Management's hybrid approach was perfectly illustrated in the $18B Hologic take-private deal. PSBD utilized its platform to act as a private credit provider in the second-lien tranche (funding $75M) while simultaneously participating in the syndicated first-lien tranches in both USD and Euros. This agility allows them to find relative value within the exact same capital structure.
Other KPIs
Stable to slightly increasing. Despite paying down total debt, the ratio ticked up from 1.53x in Q3 and 1.50x YoY. This is mathematically driven by the denominator shrinking: as NAV drops from unrealized losses, leverage mechanically increases even if no new debt is drawn.
Reversing. After posting modest positive total returns in Q2 (+1.85%) and Q3 (+1.41%), the metric turned negative in Q4. The $0.43 dividend payout was entirely erased by the $0.54 per share drop in NAV.
Guidance
Stable. The board maintained the regular base dividend at $0.36, heavily supported by the $0.41 core NII generated in Q4. A supplemental dividend is expected to be announced in March, adhering to their policy of paying out excess earnings.
Key Questions
Unrealized Depreciation Origins
You recorded $20 million in unrealized depreciation this quarter, driving NAV down significantly. Considering non-accruals are basically zero, what specific sectors, vintages, or macro inputs drove these mark-to-market hits?
Portfolio Contraction Floor
With repayments heavily outpacing originations for multiple quarters, the portfolio has shrunk by roughly $200 million this year. Is there a target AUM floor where you will be forced to deploy capital to maintain TII, or are you comfortable letting the portfolio continue to shrink until spreads widen?
Share Repurchase Execution
You noted shares yield 15.7% and trade at a significant discount to NAV, yet blackout periods prevented buybacks in Q4. Now that the window will open, should we expect aggressive, accelerated utilization of the new $5M authorization to support the stock?